DDInter679 DDInter1082
Estradiol is a naturally occurring hormone circulating endogenously in females. It is commercially available in several hormone therapy products for managing conditions associated with reduced estrogen, such as vulvovaginal atrophy and hot flashes. Some available forms of estradiol include oral tablets, injections, vaginal rings, transdermal patches, sprays, gels, and creams.[L11485,L11488,L11491, L11494,L11497,L11500,L11503] When used for oral or IM administration, estradiol is commonly synthesized as a pro-drug ester (such as,,,, and ). Because it has a low oral bioavailability on its own, estradiol is commonly formulated with an ester side-chain. (EE) is a synthetic form of estradiol commonly used as the estrogenic component of most combination oral contraceptive pills (OCPs). Ethinyl estradiol is different from estradiol due to its higher
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Estradiol {u} (Compound) resembles {v} (Compound) Estramustine
Estradiol {u} (Compound) resembles {v} (Compound) Estradiol valerate/Dienogest
Estradiol {u} (Compound) treats {v} (Disease) osteoporosis
Estradiol {u} (Compound) binds {v} (Gene) UGT1A1
Estradiol {u} (Compound) upregulates {v} (Gene) JADE2
Estradiol {u} (Compound) palliates {v} (Disease) breast cancer
Estradiol {u} (Compound) is included by {v} (Pharmacologic Class) Estrogen Receptor Agonists
Estradiol {u} (Compound) downregulates {v} (Gene) ARL4C
Estradiol {u} (Compound) causes {v} (Side Effect) Toxic reaction (NOS)
Estradiol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Hyaluronidase
Estradiol (Compound) resembles Estramustine (Compound)
Estradiol (Compound) resembles Estradiol valerate/Dienogest (Compound)
Estradiol (Compound) treats osteoporosis (Disease)
Estradiol (Compound) binds UGT1A1 (Gene)
Estradiol (Compound) upregulates JADE2 (Gene)
Estradiol (Compound) palliates breast cancer (Disease)
Estradiol (Compound) is included by Estrogen Receptor Agonists (Pharmacologic Class)
Estradiol (Compound) downregulates ARL4C (Gene)
Estradiol (Compound) causes Toxic reaction (NOS) (Side Effect)
Estradiol may cause a minor interaction that can limit clinical effects when taken with Hyaluronidase